IMI-EFOEUPATI

Eupati-projektets fremtid har til formål at sikre optimal udnyttelse og bæredygtighed af de centrale resultater af IMI-EUPATI-projektet (2012-2017): Patientekspertuddannelsen, den flersprogede offentlige værktøjskasse og EUPATI’s nationale platformsnetværk. Det er bydende nødvendigt, at disse søjler findes på mellemlang og lang sigt for at tage fat på det voksende område for patientengagement.

Mål

  • Udvikle en bæredygtig bæredygtighed/forretningsmodel for EUPATI-aktiviteternes fremtid på mellemlang sigt.
  • Opret en patientuddannelses- og engagementsportal, der vil være vært for relevante oplysninger og ressourcer for patienter og andre interessenter for at sikre meningsfuld og værdiskabende patientengagement inden for forskning og udvikling af lægemidler. Dette vil erstatte det eksisterende EUPATI-websted.
  • Styrke koordineringen og virkningen af det eksisterende NETVÆRK FOR DEN NATIONALE EUPATI-platformen (ENP) gennem fremme af samarbejde, udveksling af viden og deling.

Startdato og varighed

IMI-EFOEUPATI-projektet blev lanceret den 1.

Budget

Det budget, der modtages fra IMI JU, er 362,242.50 €

WP1 – Project Coordination

WP1 provides coordination between the different Work Packages and takes decision that govern the direction of the project, such as signing off on the design of the Patient Education and Engagement Portal, and sustainability model for which a business plan will be developed.

WP2 – Sustainability

WP2 aims the development of viable sustainability / business model for the medium – long-term future of EUPATI activities and objectives in the form of the European Patients’ Academy by identifying new funding sources and creating the necessary plans to exploit and implement them.

WP3 – Patient Education and Engagement Portal

The portal developed by WP3 will host relevant information for patients and other stakeholders in order to ensure meaningful and value adding patient engagement.

WP4 – European National Platform

WP4 aims strengthening the coordination of the existing ENP network, through promotion of collaboration, knowledge exchange and sharing.

Partners

Project Coordinator

The project is co-lead by the European Patients’ Forum (EPF) and Bayer.

Matthias Gottwald, Bayer – [email protected]

Maria Dutarte, European Patients’ Forum/EUPATI – [email protected]

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806995. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Updates on the project will be periodically posted to this web page, through the established EUPATI social media channels, and the EUPATI Newsletter.